Allianz Asset Management’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-23,602
Closed -$200K 2384
2022
Q1
$200K Sell
23,602
-64,545
-73% -$595K ﹤0.01% 2281
2021
Q4
$1.2M Buy
88,147
+7,984
+10% +$122K ﹤0.01% 1826
2021
Q3
$1.65M Buy
80,163
+362
+0.5% +$6.83K ﹤0.01% 1722
2021
Q2
$1.55M Sell
79,801
-137
-0.2% -$2.7K ﹤0.01% 1564
2021
Q1
$1.55M Buy
79,938
+27,426
+52% +$638K ﹤0.01% 1497
2020
Q4
$989K Sell
52,512
-2,412
-4% -$52.9K ﹤0.01% 1480
2020
Q3
$1.34M Buy
+54,924
New +$1.37M ﹤0.01% 1361

Other funds holding RCEL

Allianz Asset Management's RCEL Position: Q2 2022 in Review

Allianz Asset Management sold out of Avita Medical (RCEL) in Q2 2022, closing a stake of 23,602 shares — an estimated $200K sold.

Allianz Asset Management first reported a position in RCEL in Q3 2020 and held it in 7 quarters. The position peaked at $1.65M in Q3 2021. 56 funds tracked by Wall St. Rank hold RCEL as of Q2 2022.

  • Allianz Asset Management reported no remaining Avita Medical position as of Q2 2022 after selling out during the quarter.
  • Allianz Asset Management sold 23,602 Avita Medical shares in Q2 2022, an estimated $200K.
  • Allianz Asset Management first reported a position in Avita Medical in Q3 2020 and held it in 7 quarters.
  • Allianz Asset Management's Avita Medical position peaked at $1.65M in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Avita Medical as of Q2 2022.

Based on Allianz Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.